BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining ...

Drug discovery is a complex field that demands rigorous testing and comprehensive data analysis to ensure potential drug candidates can advance to clinical trials. One critical step is screening for ...

Surface plasmon resonance (SPR) has revolutionized the study of the intricate protein interactions that are required for the execution and maintenance of complex biological processes, enabling the ...

Grating-coupled interferometry (GCI) is a surface based, a label-free optical sensing technique used for real-time binding kinetic measurements. 1 Typically, GCI is used to detect binding events ...

Cell-surface proteins are critical therapeutic targets and are vital to cellular communication, signaling, and homeostasis.

Researchers at ESPCI Paris and Quantum-Si demonstrate scalable platform for parallel binding kinetics and sequencing in new preprint Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the ...

A research team led by Prof. TAN Weihong and Prof. WU Qin from the Hangzhou Institute of Medicine (HIM) of the Chinese Academy of Sciences has developed a pioneering, multi-modal platform called SPARK ...